Product image of Glucagen Hypokit (Glucagon) supplied by GNH India

Glucagen Hypokit

Active Ingredient:
Glucagon
Origin:
EU

Glucagen Hypokit (Glucagon)

Glucagen Hypokit is a glucagon‑based emergency kit marketed in the European Union. It contains the active ingredient glucagon, supplied in a ready‑to‑use format for intramuscular, intravenous, or subcutaneous administration. The product is prescription‑only and is intended for rapid treatment of severe hypoglycemia in patients with diabetes when oral glucose is not feasible. Its design supports quick dosing in emergency situations by trained caregivers or medical personnel.

Manufacturer / TM Owner

Novo Nordisk - Comércio De Produtos Farmacêuticos, Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucagen Hypokit is indicated for the immediate management of severe hypoglycemia when rapid glucose replacement is required.

  • Acute hypoglycemic episodes in adults with type 1 or type 2 diabetes.
  • Hypoglycemia unresponsive to oral carbohydrate intake.
  • Emergency treatment for children with diabetes experiencing severe low blood sugar.
  • Situations where intravenous dextrose is unavailable or delayed.
  • Use by healthcare professionals or trained individuals during a diabetic emergency.

Side Effects

The safety profile of Glucagen Hypokit reflects the pharmacologic actions of glucagon, with most reactions being mild and transient.

Common

  • Nausea or vomiting
  • Flushing or warmth sensation
  • Headache
  • Dizziness
  • Injection site pain or erythema

Serious

  • Severe allergic reaction (anaphylaxis)
  • Rapid heart rate (tachycardia) with palpitations
  • Hypotension
  • Chest discomfort or angina
  • Persistent vomiting leading to dehydration

Precautions & Warnings

When using Glucagen Hypokit, clinicians should consider several precautionary measures to ensure safe and effective administration.

  • Verify patient’s diagnosis of severe hypoglycemia before injection.
  • Assess for known hypersensitivity to glucagon or any kit components.
  • Use the correct dose and route as specified in the prescribing information.
  • Monitor vital signs and blood glucose after administration.
  • Avoid repeated dosing within a short interval unless medically indicated.
  • Store the kit according to manufacturer guidelines, protecting it from extreme temperatures.
  • Keep the kit out of reach of children.

Avoid Interactions

Glucagen Hypokit may interact with other medications or clinical conditions; awareness of these interactions helps minimize risk.

Avoid

  • Beta‑blockers, which may mask typical glucagon‑induced tachycardia.
  • Insulin or sulfonylurea overdose without appropriate glucose monitoring.
  • Medications that cause severe cardiovascular instability.

Use with caution

  • Catecholamine‑releasing agents (e.g., epinephrine) that can amplify cardiovascular effects.
  • Diuretics that may affect fluid balance during treatment.
  • Patients with pheochromocytoma or other catecholamine‑secreting tumors.

Frequently Asked Questions

Glucagen Hypokit is a ready‑to‑use glucagon emergency kit that raises blood glucose by stimulating the liver to release stored glucose, providing rapid reversal of severe hypoglycemia.

It should be given when a person with diabetes experiences a blood glucose level that is critically low and cannot be corrected by oral carbohydrate intake.

Yes, the kit can be used in pediatric patients when severe hypoglycemia occurs, provided the dose and administration route are appropriate for the child’s weight and age.

Common side effects include nausea, vomiting, flushing, headache, dizziness, and mild pain or redness at the injection site.

Store the kit at room temperature, away from direct sunlight and extreme heat or cold, and keep it in its original packaging until needed.

Beta‑blockers may mask the typical increase in heart rate caused by glucagon, so clinicians should monitor patients closely if both are used.

If signs of an allergic reaction such as rash, swelling, or difficulty breathing occur, discontinue use and seek immediate medical attention.

Blood glucose usually begins to rise within 5 to 15 minutes after intramuscular or subcutaneous injection of glucagon.

Yes, glucagon can be given intravenously if intravenous access is available, and this route may produce a faster glucose response.

Both routes are effective; intramuscular injection may deliver the drug slightly faster, while subcutaneous injection is often easier for caregivers to perform.

A second dose may be administered after 15 minutes if the first dose does not restore adequate blood glucose, but repeated dosing should be guided by a healthcare professional.

Caregivers should receive instruction on recognizing severe hypoglycemia, proper reconstitution (if required), correct injection technique, and post‑administration monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucagon

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT